Showing 101,641 - 101,660 results of 106,892 for search '(( 2 de decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.25s Refine Results
  1. 101641

    Validation that AMPA and GABA receptor timescales can scale independently. by Niklas Brake (20671067)

    Published 2025
    “…The CSD amplitudes decreased with distance following a Gaussian function with variance such that nearby neurons were more correlated than distant neurons. …”
  2. 101642

    The role of slow oscillation during two-sequence learning. by Yina Wei (783667)

    Published 2018
    “…The delay between subsequent stimuli of two groups was 5ms. Each group includes five neurons. <b>c</b>) A characteristic example of test and training of Seq1 (“A<sub>1</sub>B<sub>1</sub>C<sub>1</sub>D<sub>1</sub>E<sub>1</sub>”). …”
  3. 101643

    Table_3_Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis... by Xirui Guo (8881535)

    Published 2023
    “…The monthly average medical expenses of patients from May 2015 to August 2018 were extracted to construct an interrupted time series (ITS) model to evaluate the impact of policy implementation on the economic burden.</p>Results<p>A total of 5,764 cases were enrolled in our study. …”
  4. 101644

    Table_1_Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis... by Xirui Guo (8881535)

    Published 2023
    “…The monthly average medical expenses of patients from May 2015 to August 2018 were extracted to construct an interrupted time series (ITS) model to evaluate the impact of policy implementation on the economic burden.</p>Results<p>A total of 5,764 cases were enrolled in our study. …”
  5. 101645

    Data_Sheet_1_Identification of Unique mRNA and miRNA Expression Patterns in Bone Marrow Hematopoietic Stem and Progenitor Cells After Trauma in Older Adults.docx by Dijoia B. Darden (9019154)

    Published 2020
    “…BM was collected intraoperatively <9 days after initial injury from trauma patients with non-mild injury [ISS ≥ 9] or with shock (lactate ≥ 2, base deficit ≥ 5, MAP ≤ 65) who underwent operative fixation of a pelvic or long bone fracture. …”
  6. 101646

    <i>In vitro</i> synergistic effect of amlodipine and imipenem on the expression of the <i>AdeABC</i> efflux pump in multidrug-resistant <i>Acinetobacter baumannii</i> by Chao Hu (293389)

    Published 2018
    “…A gene silencing test verified that the mRNA expression levels of <i>adeABC</i> were decreased at 12 h and increased at 24 h, while the reversal of imipenem resistance by amlodipine disappeared at 12 h and reappeared at 24 h.…”
  7. 101647

    Table_2_Impacts of the zero mark-up policy on hospitalization expenses of T2DM and cholecystolithiasis inpatients in SC province, western China: an interrupted time series analysis... by Xirui Guo (8881535)

    Published 2023
    “…The monthly average medical expenses of patients from May 2015 to August 2018 were extracted to construct an interrupted time series (ITS) model to evaluate the impact of policy implementation on the economic burden.</p>Results<p>A total of 5,764 cases were enrolled in our study. …”
  8. 101648

    <i>Ola-tmt-opsin1b/2</i> double mutants are compensated for differential transcript changes present in <i>Ola-tmt-opsin1b</i> and <i>Ola-tmt-opsin2</i> single mutants. by Bruno M. Fontinha (9955504)

    Published 2021
    “…Box plots: single bar: median; box: first and third quartile; whiskers: minimum and maximum; each displayed data point corresponds to 1 individual biological replicate. Metadata: <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001012#pbio.3001012.s005" target="_blank">S5 Data</a>, <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001012#pbio.3001012.s010" target="_blank">S10 Data</a>, <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3001012#pbio.3001012.s011" target="_blank">S11 Data</a>.…”
  9. 101649

    Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children by Liusheng Huang (610226)

    Published 2017
    “…Due to evolving WHO HIV treatment guidelines, insufficient children were enrolled in the control group (n = 3), so the pharmacokinetic data were compared to a historical control group of 20 HIV-uninfected children 5–12 years of age who also presented with malaria and underwent identical study procedures. …”
  10. 101650

    Table_1_Exercise Physiology Impairments of Patients With Amyotrophic Lateral Sclerosis: Cardiopulmonary Exercise Testing Findings.DOCX by Ji He (40669)

    Published 2022
    “…Cardiopulmonary exercise testing (CPET) is a non-invasive accurate method used to comprehensively quantify exercise physiology in a variety of diseases. …”
  11. 101651

    Table 1_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  12. 101652

    Data Sheet 3_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  13. 101653

    Table 2_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  14. 101654

    Table 3_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  15. 101655

    Data Sheet 4_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  16. 101656

    Data Sheet 1_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  17. 101657

    Data Sheet 2_Persistent burden and health inequalities of lung cancer among adolescents and young adults, 1990-2021.docx by Jianhui Li (361790)

    Published 2025
    “…</p>Results<p>Globally, the rate of lung cancer among AYAs decreased between 1990 and 2021, with the age-standardized incidence rate (ASIR) decreasing from 1.3 (95% uncertainty interval [UI], 1.2 to 1.4) to 0.9 (95% UI, 0.8 to 1.0, AAPC = -1.2), age-standardized mortality rate (ASMR) decreasing from 1.1 (95% UI, 1.0 to 1.2) to 0.7 (95% UI, 0.6 to 0.8, AAPC = -1.4), and age-standardized disability-adjusted life years rate (ASDR) decreasing from 65.4 (95% UI, 60.2 to 71.1) to 42.1 (95% UI, 37.7 to 46.5, AAPC = -1.4). …”
  18. 101658

    Structure of the IHE model. by Dunming Xiao (20531096)

    Published 2025
    “…Neuropathy decreased by 17.3%. Proteinuria and end-stage renal disease decreased by 25.9% and 17.6% respectively. …”
  19. 101659

    Results of base case. by Dunming Xiao (20531096)

    Published 2025
    “…Neuropathy decreased by 17.3%. Proteinuria and end-stage renal disease decreased by 25.9% and 17.6% respectively. …”
  20. 101660

    Clinical efficacy data. by Dunming Xiao (20531096)

    Published 2025
    “…Neuropathy decreased by 17.3%. Proteinuria and end-stage renal disease decreased by 25.9% and 17.6% respectively. …”